Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

Q
Qadura M. - ANTI-CD3 IN COMBINATION WITH NASAL FVIII-A2 DOMAIN DECREASES FVIII INHIBITORS
  - THE SPLENIC MICRO-ENVIRONMENT AND FVIII-VWF INTERACTION ARE DETERMINANTS OF THE IMMUNOGENIC PRESENTATION OF FVIII BY DENDRITIC CELLS
  - ENHANCED TOLEROGENIC PRESENTATION OF FVIII BY ANDROGRAPHOLIDE-TREATED IMMATURE DENDRITIC CELLS
  - IMMUNOGLOBULIN ISOTYPES AND FUNCTIONAL ANTI-FVIII ANTIBODIES IN RESPONSE TO FVIII TREATMENT IN TWO STRAINS OF HEMOPHILIA A MICE
Qi J. - BETA 2 GLYCOPROTEIN I PROTECTS THROMBIN FROM INHIBITION BY HEPARIN COFACTOR II: LOSS OF ACTIVITY BY PROTEOLYTICALLY CLIPPED BETA 2 GLYCOPROTEIN I
Qin P. - THE SCREENING ASSAY OF PLATELET- ASSOCIATED IMMUNOGLOBULIN G CAN NOT IMPROVE THE SENSITIVITY OF MONOCLONAL ANTIBODY IMMOBILIZATION OF PLATELET ANTIGENS ASSAY IN IMMUNE THROMBOCYTOPENIC PURPURA
Qiu Y.R. - CONSTRUCTION AND IDENTIFICATION OF LENTIVIRUS - MEDIATED RNAI VECTORS CONTAINING HUMAN TISSUE FACTOR
Qiu L. - COMPARISON OF EFFICACY AND SAFETY OF INTRAVENOUS AND INTRA-ARTERIAL THROMBOLYSIS IN ACUTE ISCHEMIC STROKE
Qu C. - ESTABLISHMENT OF A FLOW CYTOMETRIC ASSAY FOR QUANTITATIVE DETECTION OF HUMAN PLATLET GLYCOPROTEIN VI BY A MOUSE POLYCLONAL ANTIBODY
Quadros L. - CONTRIBUTION OF NATURAL ANTICOAGULANT AND FIBRINOLYTIC FACTORS IN MODULATING THE CLINICAL SEVERITY OF HEMOPHILIA PATIENTS
Quah T.C. - GASTROINTESTINAL BLEEDING DUE TO MECKEL'S DIVERTICULUM IN A HEMOPHILIAC WITH INHIBITORS
Quaquaruccio G. - INTERLEUKIN-1B GENE HAPLOTYPES AND INFLAMMATORY/PROCOAGULANT RESPONSE OF HUMAN MONONUCLEAR CELLS
  - INTERLEUKINS GENES TAG-SNP HAPLOTYPES AND RISK OF MYOCARDIAL INFARCTION: A POPULATION BASED CASE-CONTROL STUDY
  - TISSUE FACTOR GENE TAG-SNPS AND HAPLOTYPES AND THE RISK OF MYOCARDIAL INFARCTION
Quarentei R. - DELAYED ONSET OF LOW MOLECULAR WEIGHT HEPARIN INDUCED THROMBOCYTOPENIA TYPE II IN A CARDIAC PATIENT
Quarta G. - PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
Que N.S. - DEVELOPING ANTIDOTE CONTROLLED ANTIPLATELET THERAPIES BY TARGETING THE VWF - GP IB-IX-V INTERACTION
Quehenberger P. - EFFECTS OF RECOMBINANT FACTOR VIIA (NOVOSEVEN) ON RESTORING THROMBIN GENERATION IN PATIENTS WITH HEMOPHILIA A AND ANTIBODIES TO FACTOR VIII
  - RISK OF RECURRENCE AFTER A FIRST VENOUS THROMBOEMBOLIC EVENT IN YOUNG WOMEN
  - FUNCTIONAL COAGULATION ANALYSIS IN PATIENTS WITH BLOOD COAGULATION DISORDERS OR HYPERCOAGULABILITY: SIGNIFICANCE OF WHOLE BLOOD ROTATION THROMBELASTOGRAPHY IN COMPARISON WITH CONVENTIONAL BLOOD COAGULATION ANALYSIS
  - SUCCESSFUL PREGNANCY OUTCOME IN A WOMAN WITH HOMOZYGOUS ANTITHROMBIN DEFICIENCY (99 LEUPHE MUTATION)
  - A HIGH PLATELET COUNT INDEPENDENTLY PREDICTS VENOUS THROMBOEMBOLISM IN CANCER PATIENTS
  - SERIAL MONITORING OF ADAMTS13- AND VWF-RELATED PARAMETERS IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA: PREDICTION OF RESPONSE TO THERAPY, RISK OF RELAPSE, AND LONG-TERM COURSE
  - SOLUBLE P-SELECTIN AND THE RISK OF THROMBOTIC EVENTS IN PATIENTS WITH A LUPUS ANTICOAGULANT IN A PROSPECTIVE COHORT STUDY
Quenet S. - LATE BREAKING CLINICAL TRIAL: ANTICOAGULANT CLINICS-BASED SHARED-CARE VERSUS GENERAL PRACTITIONERS MANAGEMENT OF ORAL ANTICOAGULANTS: A PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY
  - RENAL IMPAIRMENT ESTIMATES TO PREDICT THE HAEMORRHAGE RISK IN 2170 PATIENTS TREATED BY HEPARIN. COCKCROFT-GAULT OR SIMPLIFIED MDRD?
  - DOES TRANEXAMIC ACID DECREASE ERYTHROCYTE TRANSFUSION IN PATIENTS UNDERGOING HIP FRACTURE SURGERY WITH FONDAPARINUX FOR PREVENTION OF VENOUS THROMBOEMBOLISM ?
  - RETRIEVABLE VENA CAVA FILTERS FOR SECONDARY PREVENTION OF PULMONARY EMBOLISM IN ORTHOPAEDIC SURGERY
Quére I. - CLINICAL RISK FACTORS AND 3 MONTHS OUTCOMES OF SYMPTOMATIC CALF VEIN THROMBOSIS: FINDINGS FROM THE OPTIMEV COHORT
Quéré I. - SYMPTOMATIC THROMBOSIS COMPLICATIONS IN VENOUS MALFORMATION
  - THREE-MONTH INCIDENCE OF VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH ISOLATED SUPERFICIAL THROMBOPHLEBITIS (ST): PRELIMINARY RESULTS OF THE POST STUDY
  - THE RISK OF UNEXPLAINED FOETAL LOSS IS DOSE-DEPENDENTLY RELATED TO THE EXPRESSION OF THE GLY219 VARIANT OF THE ENTOTHELIAL PROTEIN C RECEPTOR BY THE MOTHER, BY THE FATHER AND BY THE COUPLE
  - ASYMPTOMATIC CARRIAGE OF THE JAK2V617F MUTATION IS ASSOCIATED WITH UNEXPLAINED EMBRYONIC AND FOETAL LOSS DURING THE FIRST PREGNANCY
  - RISK FACTORS FOR CONCOMITANT VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH SUPERFICIAL THROMBOPHLEBITIS (ST): PRELIMINARY RESULTS OF THE POST STUDY
Quesne J. - NEONATAL ALLOIMMUNE THROMBOCYTOPENIA DUE TO RARE PLATELET ALLOANTIGENS
Quiazon E. - LIQUID HEPARIN ASSAY: RAPID MONITORING OF CLINICALLY USED HEPARINS
Quilici J. - CYP 2C19*2 AND MDR1+3435C ALLELES CONTRIBUTE TO LOW RESPONSE TO CLOPIDOGREL IN ACUTE CORONARY SYNDROME
Quinlan D.J. - ASSOCIATION BETWEEN ASYMPTOMATIC DEEP-VEIN THROMBOSIS DETECTED BY SCREENING VENOGRAPHY AND SYMPTOMATIC VENOUS THROMBOEMBOLISM IN PATIENTS UNDERGOING ELECTIVE HIP OR KNEE SURGERY A SYSTEMATIC REVIEW
Quinn-Allen M. - THE ROLE OF THE FACTOR V B DOMAIN IN FACTOR V-MMRN1 BINDING AND DISSOCIATION
Quintana M. - ORTHOPAEDIC SURGERY IN TWO HAEMOPHILIC PATIENTS WITH HIGH-RESPONSE INHIBITORS
  - ACUTE CORONARY SYNDROME AND MEAN PLATELET VOLUME
  - CAN BLOOD HIPERVISCOSITY BE A PREDICTOR OF ACUTE CORONARY SYNDROME?
  - DEFINITIVE PACEMAKER'S IN ANTICOAGULATED PATIENTS
  - IMMUNE TOLERANCE INDUCTION WITH VIII-CONTAINING FACTOR VWF
Quintana-Molina M. - RADIOSYNOVIORTHESIS IS NECESSARY IN HEMOPHILIC PATIENTS DESPITE PROHYLAXIS
  - SURGERY IN HEMOPHILIA PATIENTS WITH INHIBITORS: REPORT OF 91 SURGICAL PROCEDURES
Quintavalla R. - PREVENTION OF RECURRENT THROMBOEMBOLISM BY ADJUSTING THE DURATION OF ANTICOAGULATION ACCORDING TO RESIDUAL VEIN THROMBOSIS. A RANDOMIZED STUDY
Quintini G. - PLASMA EXCHANGE AND ASPIRIN PLUS HIGH VERSUS STANDARD DOSE STEROIDS IN IDIOPATHIC THROMBOCYTOPENIC PURPURA (TTP): A PROSPECTIVE, RANDOMIZED STUDY BY THE ITALIAN GROUP FOR PTT
Quinto F. - THE KOGEOGPK PEPTIDE FROM TYPE III COLLAGEN INHIBITS BREAST ADENOCARCINOMA CELL ADHESION TO TYPE III COLLAGEN AND HUVEC MATRIX IN WHOLE BLOOD AND UNDER FLOW CONDITIONS
Quiroga T. - PLASMA PROCPU (TAFI) AND CLOT LYSIS TIME ARE CORRELATED WITH CLOTTING FACTOR LEVELS AND THROMBIN GENERATION: A NOVEL APPROACH TO ASSESS THROMBOSIS RISK?
  - PLASMA LEVELS OF CLOTTING FACTORS ARE POSITIVELY CORRELATED IN HEALTHY POPULATION: A COMPREHENSIVE PERSPECTIVE TO ASSESS THROMBOTIC RISK?
  - TRANEXAMIC ACID DELAYS THE CLOT LYSIS TIME, AND INCREASES THE ENDOGENOUS THROMBIN GENERATION AND PLASMA PROCARBOXYPEPTIDASE U (TAFI) LEVELS IN PATIENTS WITH MUCOCUTANEOUS BLEEDING
| ISTH 2009